Cells Lacking the Tumor Suppressor Gene Are Hyperdependent on Aurora B Kinase for Survival.
Small cell lung cancer (SCLC) accounts for 15% of lung cancers and is almost always linked to inactivating and mutations. SCLC frequently responds, albeit briefly, to chemotherapy. The canonical function of the gene product RB1 is to repress the E2F transcription factor family. RB1 also plays both E2F-dependent and E2F-independent mitotic roles. We performed a synthetic lethal CRISPR/Cas9 screen in an SCLC cell line that conditionally expresses to identify dependencies that are caused by RB1 loss and discovered that SCLC cell lines are hyperdependent on multiple proteins linked to chromosomal segregation, including Aurora B kinase. Moreover, we show that an Aurora B kinase inhibitor is efficacious in multiple preclinical SCLC models at concentrations that are well tolerated in mice. These results suggest that RB1 loss is a predictive biomarker for sensitivity to Aurora B kinase inhibitors in SCLC and perhaps other cancers. SIGNIFICANCE: SCLC is rarely associated with actionable protooncogene mutations. We did a CRISPR/Cas9-based screen that showed that SCLC are hyperdependent on , likely because both genes control mitotic fidelity, and confirmed that Aurora B kinase inhibitors are efficacious against SCLC tumors in mice at nontoxic doses...
|Year of Publication
|PubMed Central ID
P50 CA101942 / CA / NCI NIH HHS / United States
R35 CA210068 / CA / NCI NIH HHS / United States
T32 CA009172 / CA / NCI NIH HHS / United States
K08 CA222657 / CA / NCI NIH HHS / United States
R01 CA213404 / CA / NCI NIH HHS / United States
Wellcome Trust / United Kingdom
K08 CA208008 / CA / NCI NIH HHS / United States
P30 CA006516 / CA / NCI NIH HHS / United States
P50 CA165962 / CA / NCI NIH HHS / United States
CRUK_ / Cancer Research UK / United Kingdom
R01 CA076120 / CA / NCI NIH HHS / United States
HHMI_ / Howard Hughes Medical Institute / United States